Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics

Elisabeth S. Prosser*, John G. Csernansky, Jonathan Kaplan, Sue Thiemann, Thomas J. Becker, Leo E. Hollister

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

113 Scopus citations


To determine whether depression and neuroleptic-induced parkinsonism confound the clinical assessment of negative symptoms in schizophrenics, we evaluated 45 outpatient schizophrenics for depression, parkinsonian symptoms, and negative symptoms using standard clinical rating scales. Neuroleptic and anticholinergic dose and plasma activity were also determined. Associations between negative symptoms and these clinical and drug variables were examined using a multivariate statistical model. Negative symptoms were significantly correlated with several parkinsonian symptoms, some vegetative features of depression, and with anticholinergic dose. No significant correlations were found between negative symptoms and cognitive features of depression, or neuroleptic and anticholinergic plasma activity. These findings suggest that assessment criteria for negative symptoms, depression, and drug-induced parkinsonism overlap in treated schizophrenics. Strategies for differentiating these clinical syndromes are discussed.

Original languageEnglish (US)
Pages (from-to)100-105
Number of pages6
JournalJournal of Nervous and Mental Disease
Issue number2
StatePublished - Feb 1987

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics'. Together they form a unique fingerprint.

Cite this